1 study on Norrin curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research highlights Norrin as a promising therapeutic agent for Diabetic Retinopathy, offering a novel approach that simultaneously targets RGC neuroprotection and vascular stability by rebalancing VEGF and PEDF.…